Paraneoplastic endocrinopathies associated with renal tumors.
D000236:Adenoma / Q000150:complications; D000324:Adrenocorticotropic Hormone / Q000378:metabolism; D004921:Erythropoietin / Q000378:metabolism; D005260:Female; D004763:Glucagon-Like Peptides / Q000378:metabolism; D006062:Gonadotropins / Q000378:metabolism; D006729:Hormones, Ectopic / Q000378:metabolism*; D006801:Humans; D006934:Hypercalcemia / Q000150:complications; D007223:Infant; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007680:Kidney Neoplasms / Q000097:blood / Q000150:complications / Q000201:enzymology / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000378:metabolism; D010282:Parathyroid Neoplasms / Q000150:complications; D010928:Placental Lactogen / Q000097:blood; D011388:Prolactin / Q000378:metabolism; D011454:Prostaglandins A / Q000097:blood; D012083:Renin / Q000378:metabolism
D006062:Gonadotropins; D006729:Hormones, Ectopic; D007328:Insulin; D010281:Parathyroid Hormone; D011454:Prostaglandins A; D004921:Erythropoietin; D004763:Glucagon-Like Peptides; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D010928:Placental Lactogen; D012083:Renin